Author

Jon Bjørn

Observed name: Bjørn, Jon

Institutions: Copenhagen University Hospital, Rigshospitalet

Observed institutions: Herlev Hospital, Copenhagen University Hospital, Rigshospitalet

OpenAlex ID: A5064339706

Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial

2010 · Redas Trepiakas, Annika Berntsen, et al. · Cytotherapy · 81

Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients

2020 · Lasse H. Jakobsen, Fredrik Ellin, et al. · British Journal of Haematology · 24

Abstracts from the 38th Annual Meeting of the Histiocyte Society Held Virtually and In Person in Stockholm, Sweden from September 18‐20, 2022

2022 · Bjørn, Jon, Brooks, Patrick Terrence, et al. · Pediatric Blood & Cancer · 14

Normalization of Survival and No Relapses after One Year in Adult Burkitt Lymphoma Patients Treated with Intensive Immunochemotherapy: An International Study of 159 Real-World Patients

2018 · Lasse H. Jakobsen, Fredrik Ellin, et al. · Blood

Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma

2013 · Jon Bjørn, Marco V Donia, et al. · Journal for ImmunoTherapy of Cancer

Works count: 5

Citation count: 119

H-index: 3

I10-index: 3